These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 23639554
1. Activation of human natural killer cells by the novel innate immune modulator recombinant Eimeria antigen. Aylsworth CF, Aldhamen YA, Seregin SS, Godbehere S, Amalfitano A. Hum Immunol; 2013 Aug; 74(8):916-26. PubMed ID: 23639554 [Abstract] [Full Text] [Related]
2. Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists. Hamm S, Rath S, Michel S, Baumgartner R. J Immunotoxicol; 2009 Dec; 6(4):257-65. PubMed ID: 19848448 [Abstract] [Full Text] [Related]
3. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells. Offersen R, Nissen SK, Rasmussen TA, Østergaard L, Denton PW, Søgaard OS, Tolstrup M. J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036 [Abstract] [Full Text] [Related]
4. Exposure to cigarette smoke suppresses IL-15 generation and its regulatory NK cell functions in poly I:C-augmented human PBMCs. Mian MF, Pek EA, Mossman KL, Stämpfli MR, Ashkar AA. Mol Immunol; 2009 Sep; 46(15):3108-16. PubMed ID: 19592095 [Abstract] [Full Text] [Related]
5. Natural killer cells display impaired responses to toll like receptor 9 that support viral persistence in chronic hepatitis B. Ratnam DT, Sievert W, Visvanathan K. Cell Immunol; 2012 Sep; 279(1):109-15. PubMed ID: 23123793 [Abstract] [Full Text] [Related]
10. Manipulation of EAT-2 expression promotes induction of multiple beneficial regulatory and effector functions of the human innate immune system as a novel immunomodulatory strategy. Aldhamen YA, Seregin SS, Aylsworth CF, Godbehere S, Amalfitano A. Int Immunol; 2014 May; 26(5):291-303. PubMed ID: 24374770 [Abstract] [Full Text] [Related]
11. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells. Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H. Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295 [Abstract] [Full Text] [Related]